Pharmacoinvasive Therapy in Acute Myocardial Infarction.(Brief Article)(Book Review)

Schering-Plough Corporation (Kenilworth, NJ) announced the worldwide licensing of acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA), from PeriCor Therapeutics, Inc., a privately held, specialty biopharmaceutical company. Acadesine is currently under evaluation in Phase III clinical development as an intravenous infusion for the prevention of ischemia-reperfusion injury, a ......

ABSTRACT. Revascularization of the left anterior descending coronary artery is an important, evolving and controversial topic. There are differences in patient selection, hospital stay and readmission, and hospital cost. We reviewed our institutional experience in 190 consecutive patients who underwent isolated initial left anterior descending revascularization via angioplasty, angioplasty plus ......

INTRODUCTION The gap between black and white patients in the use of "high-tech" cardiac procedures has been well documented in studies employing a wide range of data sources, including Medicare claims (Ayanian et al., 1993; Boutwell and Mitchell, 1993; Escarce et al., 1993; Goldberg et al., 1992; Udvarhelyi et al., ......

HEADNOTE The National Service Framework (NSF) for Coronary Heart Disease, published in the UK in 2000, gave target intervention rates of 750 procedures per million population (pmp) for both percutaneous transluminal angioplasty (PTCA) and coronary artery bypass graft (CABG). This paper describes how one Regional Office of the Department of ......

A drug prescribed annually to about 250,000 patients undergoing heart by-pass surgery doubles the risk of kidney failure, and also significantly increases the risk of heart failure, heart attack, and stroke, according to a study in the New England Journal of Medicine (NEJM). The drug, aprotinin, sold under the brand ......

A German man who received stem cells to repair heart damage caused by a myocardial infarction is doing well 2 weeks after the ground-breaking procedure. Hematopoietic cells and mesenchymal stem cells from the man's bone marrow were directly injected into his heart during coronary artery bypass grafting, reported surgeons at ......

Additional Payment per Case for Year One and Year Two to Hospitals Performing in the Top 20 Percent Year 1 payment Year 2 payment per case per case Acute Myocardial Infarction $175 $172 Coronary Artery Bypass Graft $447 $388 Heart Failure $100 $117 Community Acquired Pneumonia $95 $86 Hip ......

I don't do a lot of book reviews but every now and then one crosses my desk that I have to tell you about. A few weeks ago, I read a book by my friend and fellow AllBusiness blogger, Denise O'Berry. It's worth mentioning.

Regular Management Craft reader and commenter Wally Bock (check out Wally's blog, Three Star Leadership ) offers this book review of The GO Point by Michael Useem . Thanks Wally! If you want to make better decisions, you should read The GO Point by Michael Useem.  The subtitle is: ......

I recently finished reading Lisa Haneberg's latest book, Focus Like A Laser Beam: 10 Ways To Do What Matters Most , and I also had a chance to chat with her via Skype, which she'll put out as a podcast pretty soon. I'll point to that when it's up....

According to a new Harvard Study, using ER as back-up may be dangerous to your patients -- and your practice.